arrow_back Back to App

Study on Efficacy of Federal Drug Surveillance Systems in the US

This act mandates a study on the effectiveness of federal drug surveillance systems in the United States. The goal is to assess their ability to provide up-to-date information on illicit drug use and how this data is used to combat the drug problem. The study's findings will help improve government actions in public health and safety, potentially leading to better support for individuals affected by drug addiction.
Key points
Mandates a study on the efficacy of federal drug surveillance systems, including DOSE, SUDORS, NDEWS, and DAWN.
The study report will include findings, conclusions, and recommendations for improving these systems, including interagency communication and data collection.
Aims to enhance understanding of the drug problem in the US and improve government responses.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_6045
Sponsor: Rep. Caraveo, Yadira [D-CO-8]
Process start date: 2023-10-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Curbing Illicit Drug Threats Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_6045.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-10-25.

What are the main provisions?

Key points include:

  • Mandates a study on the efficacy of federal drug surveillance systems, including DOSE, SUDORS, NDEWS, and DAWN.
  • The study report will include findings, conclusions, and recommendations for improving these systems, including interagency communication and data collection.
  • Aims to enhance understanding of the drug problem in the US and improve government responses.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Caraveo, Yadira [D-CO-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Security